Yingxi Lin.

Yingxi Li

Professor of psychiatry and neuroscience
University of Texas Southwestern Medical Center

Yingxi Li is professor of psychiatry and neuroscience, and chief of the Psychiatry Neuroscience Research Division at University of Texas Southwestern Medical Center. Her research focuses on uncovering molecular and circuit mechanisms in neurodevelopment, memory formation and neuropsychiatric conditions. Employing a broad array of multidisciplinary experimental techniques, work in her lab spans analyses from the genomic and molecular level to synapse, circuit and whole-animal behavioral levels.

Originally from China, Lin studied engineering physics at Tsinghua University and received her Ph.D. in biophysics from Harvard University. She conducted her postdoctoral research under Michael Greenberg at Harvard Medical School. She was assistant professor from 2009 to 2015 and associate professor from 2015 to 2018 at the McGovern Institute for Brain Research at the Massachusetts Institute of Technology. Prior to her current role, she was full professor and director of the Neuroscience Graduate Program at SUNY Upstate Medical University.

Explore more from The Transmitter

A human arm and a robot arm write code together on a small blackboard.

How to teach programming in the age of AI

Scientists and educators are concerned about students using artificial intelligence to shortcut their learning. But there are also opportunities, especially when it comes to teaching neuroscience students how to code.

By Ashley Juavinett
30 March 2026 | 8 min read
A blue comment bubble is pinned down by crisscrossing red threads and pins.

Neuroscience conference policy draws confusion, apology

NeurIPS organizers apologized and altered course after issuing a policy that barred submissions from researchers at U.S.-government-sanctioned institutions.

By Dalmeet Singh Chawla
27 March 2026 | 5 min read
Assembloids in a petri dish.

Funding for animal research alternatives reaches ‘inflection point’

The United States and Europe are dedicating hundreds of millions of dollars in funding to advance novel alternative methods, but not all neuroscientists see this as a positive step.

By Claudia López Lloreda
26 March 2026 | 4 min read